NCT03727113View on ClinicalTrials.gov

Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors

CompletedOBSERVATIONAL
Enrollment

211

Participants

Timeline

Start Date

January 16, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Hematopoietic Stem Cell TransplantationGraft Versus Host Disease
Interventions
PROCEDURE

Optimization cohort

Recipients of an allogeneic hemopoietic stem cell transplant in Centers using an optimization/antibiotic strategy.

PROCEDURE

Control cohort

Recipients of an allogeneic hemopoietic stem cell transplant in Centers using a classical strategy of administration of antibiotics.

Trial Locations (5)

28007

Gregorio Marañón University Hospital, Madrid

37007

Salamanca University Hospital, Salamanca

39008

Marqués de Valdecilla University Hospital, Santander

41013

Virgen del Rocío University Hospital, Seville., Seville

46010

University Clinical Hospital of Valencia, Valencia

All Listed Sponsors
collaborator

Grupo Espanol de trasplantes hematopoyeticos y terapia celular

OTHER

collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT03727113 - Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors | Biotech Hunter | Biotech Hunter